LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | R406 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4000 | 4513 | 0.8864 | 0.8435 |
MDA-MB-231 | Pictilisib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2976 | 4513 | 0.6593 | 0.5309 |
MDA-MB-231 | Gefitinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4362 | 4513 | 0.9665 | 0.9538 |
MDA-MB-231 | Geldanamycin | 1.11 | uM | LJP5 | 72 | hr | 1235 | 842 | 4513 | 0.1867 | -0.1200 |
MDA-MB-231 | Geldanamycin | 1.11 | uM | LJP6 | 72 | hr | 1235 | 674 | 4513 | 0.1494 | -0.1714 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2452 | 4513 | 0.5433 | 0.3711 |
MDA-MB-231 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2124 | 4513 | 0.4707 | 0.2710 |
MDA-MB-231 | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3966 | 4513 | 0.8787 | 0.8329 |
MDA-MB-231 | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 966 | 4513 | 0.2141 | -0.0823 |
MDA-MB-231 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4524 | 4513 | 1.0024 | 1.0033 |
MDA-MB-231 | GW843682X | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1076 | 4513 | 0.2385 | -0.0487 |
MDA-MB-231 | HG-5-113-01 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1598 | 4513 | 0.3540 | 0.1105 |
MDA-MB-231 | HG-5-88-01 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4031 | 4513 | 0.8932 | 0.8530 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4279 | 4513 | 0.9482 | 0.9286 |
MDA-MB-231 | JNK-9L | 1.11 | uM | LJP6 | 72 | hr | 1235 | 863 | 4513 | 0.1913 | -0.1137 |
MDA-MB-231 | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2889 | 4513 | 0.6402 | 0.5045 |
MDA-MB-231 | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4123 | 4513 | 0.9136 | 0.8810 |
MDA-MB-231 | LDN-193189 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3301 | 4513 | 0.7314 | 0.6301 |
MDA-MB-231 | Linifanib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4890 | 4513 | 1.0835 | 1.1149 |
MDA-MB-231 | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 3795 | 4513 | 0.8409 | 0.7809 |
MDA-MB-231 | Mitoxantrone | 1.11 | uM | LJP5 | 72 | hr | 1235 | 451 | 4513 | 0.1000 | -0.2394 |
MDA-MB-231 | Mitoxantrone | 1.11 | uM | LJP6 | 72 | hr | 1235 | 456 | 4513 | 0.1010 | -0.2380 |
MDA-MB-231 | MK2206 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3694 | 4513 | 0.8186 | 0.7501 |
MDA-MB-231 | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2421 | 4513 | 0.5365 | 0.3618 |
MDA-MB-231 | Nilotinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4108 | 4513 | 0.9102 | 0.8763 |